United Kingdom

Oncimmune Holdings plc

Track

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 23 Oct 2024
Value £2,365,987.40 | Price 202.53 | Shares 17,922
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-11 2024-10-23 B Purchase
2.1
John Goold

Non-Executive Director

Executive Director
17,922
202.53
£2,365,987 		17,922 202.53 £2,365,987
2024-11-11 2024-10-23 B Purchase
2.3
Martin Gouldstone

Chief Executive Officer

Officer
30,106
131.53
£631,063 		30,106 131.53 £631,063
2024-11-11 2024-10-23 B Purchase
2.2
Alistair Macdonald

Chairman

Director
78,860
42.34
£3,225,959 		78,860 42.34 £3,225,959
2023-12-11 2023-12-08 B Purchase Mr Martin Gouldstone

Chief Executive Officer

Officer
36,023
0.27
£9,816 		36,023 0.27 £9,816
2023-06-05 2023-06-05 B Purchase Dr Adam Mark Hill

Chief Executive Officer

Officer
48,370
0.21
£9,990 		48,370 0.21 £9,990
2022-12-19 2022-12-16 B Purchase Tim Bunting

Non-Executive Director

Executive Director
1,900,000
0.45
£855,000 		1,900,000 0.45 £855,000
2022-12-19 2022-12-16 B Purchase
2.2
Alistair Macdonald

Non-Executive Chairman

Director
55,555
0.45
£25,000 		55,555 0.45 £25,000
2022-09-21 2022-09-21 B Purchase Dr Adam Mark Hill

Chief Executive Officer

Officer
8,005
0.62
£5,000 		8,005 0.62 £5,000
2022-03-29 2022-03-25 S Sale
3.0
Matthew Hall

Chief Financial Officer

Officer
10,000
1.35
£13,500 		10,000 1.35 £13,500
2022-03-29 2022-03-24 S Sale
3.0
Matthew Hall

Chief Financial Officer

Officer
20,000
1.40
£28,000 		20,000 1.40 £28,000
2022-03-07 2022-03-07 B Purchase Dr Adam Mark Hill

Chief Executive Officer

Officer
7,533
1.33
£10,000 		7,533 1.33 £10,000
2021-12-24 2021-12-23 B Purchase Dr Adam Mark Hill

Chief Executive Officer

Officer
5,669
1.68
£9,498 		5,669 1.68 £9,498
2021-12-21 2021-12-21 B Purchase Dr Adam Mark Hill

Chief Executive Officer

Officer
5,988
1.67
£10,000 		5,988 1.67 £10,000
2021-01-14 2021-01-11 S Sale Dr Cheung To

Non-Executive Director

Through Genostics Company Limited, a closely affiliated person Executive Director
40,000
1.85
£74,000 		40,000 1.85 £74,000
2021-01-14 2021-01-08 S Sale Dr Cheung To

Non-Executive Director

Through Genostics Company Limited, a closely affiliated person Executive Director
10,000
1.85
£18,500 		10,000 1.85 £18,500
2021-01-14 2021-01-05 S Sale Dr Cheung To

Non-Executive Director

Through Genostics Company Limited, a closely affiliated person Executive Director
50,000
1.75
£87,500 		50,000 1.75 £87,500
2021-01-14 2021-01-05 S Sale Dr Cheung To

Non-Executive Director

Through Genostics Company Limited, a closely affiliated person Executive Director
50,000
0.00
£2 		50,000 0.00 £2
2021-01-14 2020-12-21 S Sale Dr Cheung To

Non-Executive Director

Through Genostics Company Limited, a closely affiliated person Executive Director
5,000
1.70
£8,500 		5,000 1.70 £8,500
2020-12-18 2020-12-17 B Purchase Dr Adam Mark Hill

Chief Executive Officer

Officer
5,764
1.73
£9,999 		5,764 1.73 £9,999
2021-01-14 2020-12-14 S Sale Dr Cheung To

Non-Executive Director

Through Genostics Company Limited, a closely affiliated person Executive Director
30,000
0.00
£2 		30,000 0.00 £2
Explore more

More insider trading research around Oncimmune Holdings plc

More insider trades in United Kingdom
Insider trading in Europe